Frontiers in Anti-Infective Drug Discovery: Volume 4

Volume in the series

Frontiers in Anti-infective Drug Discovery

Publisher:Bentham Science

By: Atta-ur Rahman and M. Iqbal Choudhary

Paid access

|Jul 2015

E-Book €105.99Institutions €422.95

Description

This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics including rational drug design and drug discovery medicinal chemistry in-silico drug design combinatorial chemistry high-throughput screening drug targets recent important patents and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The fourth volume of this series features 5 chapters that cover the following topics:
- An overview of the incidence of neuraminadase resistance in influenza viruses in the Americas from 2004 to 2014
- Phenothiazines and derivative compounds for treating Trypanosoma cruzi infections
- New antibacterial drug targets such as polysaccharide deacetylases
- Improvements in aminoglycoside synthesis and biological activity (including RNA targeting)
- A review of new chemotherapeutic agents against common infections.

Authors

Metrics

PDF ISBN: 978-1-68108-082-6

Publisher: Bentham Science

Publication date: 2015

Language: English

Pages: 230

Related subjects:

Medicine,

Clinical medicine,

Pharmacology, toxicology